Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers.
about
Recent Advances in Application of Pharmacogenomics for BiotherapeuticsGenotypes Affecting the Pharmacokinetics of Anticancer Drugs.Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome.Update on subcutaneous methotrexate for inflammatory arthritis and psoriasis.Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the Models.Clinical-pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritis.
P2860
Q29247996-FC47BA41-DF8E-4C53-B71E-C7BC08975330Q37685527-1CF0575F-A23E-4085-AE6D-1608FF59560EQ38936379-9A821862-2AA5-425A-B955-53ECC9C13668Q40564193-6A4000A8-7EBD-473C-85C4-5FC94D2E1F63Q49163962-E83DF1AE-D604-4268-AA78-FA08E6978B88Q49527931-C8007360-9BAD-4144-9272-CE8052FCC804Q53093606-315B9720-579F-4D57-8DEE-1E02BDAB055C
P2860
Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Genetic polymorphisms in low-d ...... herapeutic outcome biomarkers.
@en
type
label
Genetic polymorphisms in low-d ...... herapeutic outcome biomarkers.
@en
prefLabel
Genetic polymorphisms in low-d ...... herapeutic outcome biomarkers.
@en
P2860
P50
P356
P1433
P1476
Genetic polymorphisms in low-d ...... herapeutic outcome biomarkers.
@en
P2860
P304
P356
10.2217/PGS.14.116
P577
2014-01-01T00:00:00Z